Radians appoints Cal Bontemps as Director of Marketing
During his 18-year tenure at Medtronic, a global producer of medical devices and therapies, Bontemps showcased exceptional vision and orchestrated numerous omni-channel marketing campaigns, generating multi-million-dollar sales by introducing groundbreaking new therapies into the medical industry.
In his new role at Radians, Bontemps will oversee and execute the company's comprehensive marketing and customer engagement strategy. His primary focus will be to enhance brand visibility and deliver cutting-edge solutions that cater to the unique needs of distributors and stakeholders.
"We are excited to welcome Cal to the team," said Radians President
Bontemps is thrilled to assume the leadership role of the Radians marketing team, bringing a wealth of expertise and enthusiasm that will propel the company to even greater heights in the future. "Medical devices and PPE share the common goal of bringing health and safety to others, so, I feel right at home here. I look forward to shaping the company's strategy in the coming years, leveraging data-driven approaches to create compelling success stories for both Radians and the customers we serve," said Bontemps.
For more information, visit www.radians.com or call toll-free 1-877-723-4267.
Radians® is a
View original content to download multimedia:https://www.prnewswire.com/news-releases/radians-appoints-cal-bontemps-as-director-of-marketing-302116791.html
SOURCE Radians
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Radiowell Study Finds 35% of Two-Way Radios Sold at Auction Still Contain Sensitive Data
- Beasley Broadcast Group Announces Postponement of Reporting of Q2 2026 Financial Results and Date of Conference Call and Webcast
- The 16th Worldwide Chinese Life Insurance Congress & 2026 International Dragon Award (IDA) Annual Conference Grandly Held
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share